Choi Moon-Chang, Lee Yang-Ui, Kim Sung-Hak, Park Jung-Hyun, Kim Hyun-Ah, Oh Do-Youn, Im Seock-Ah, Kim Tae-You, Jong Hyun-Soon, Bang Yung-Jue
National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul, Republic of Korea.
Biochem Biophys Res Commun. 2008 Aug 15;373(1):85-9. doi: 10.1016/j.bbrc.2008.05.184. Epub 2008 Jun 11.
A-kinase anchoring protein 12 (AKAP12) gene is frequently inactivated in human gastric cancer and in several other cancers due to promoter hypermethylation. However, the biological function of AKAP12 in tumorigenesis remains to be identified. Aneuploidy, a hallmark of cancer cells, is often caused by abnormal cell division. In the present study, AKAP12 was found to localize to the cell periphery during interphase and to the actomyosin contractile ring during cytokinesis. Furthermore, AKAP12 depletion using small interfering RNA increased the number of multinucleated cells, and disrupted the completion of cytokinesis. Interestingly, the inhibition of myosin light chain kinase (MLCK), a key regulator of actomyosin contractility, removed AKAP12 from the cell periphery during interphase and from the contractile ring during cytokinesis, suggesting that AKAP12 might be a downstream effector of MLCK. Our findings implicate AKAP12 in the regulation of cytokinesis progression, and suggest a novel role for AKAP12 tumor suppressor.
A激酶锚定蛋白12(AKAP12)基因在人类胃癌及其他多种癌症中常因启动子高甲基化而失活。然而,AKAP12在肿瘤发生中的生物学功能仍有待确定。非整倍体是癌细胞的一个标志,通常由异常细胞分裂引起。在本研究中,发现AKAP12在间期定位于细胞周边,在胞质分裂期间定位于肌动球蛋白收缩环。此外,使用小干扰RNA耗尽AKAP12会增加多核细胞的数量,并破坏胞质分裂的完成。有趣的是,抑制肌动球蛋白收缩性的关键调节因子肌球蛋白轻链激酶(MLCK),会在间期将AKAP12从细胞周边移除,并在胞质分裂期间将其从收缩环移除,这表明AKAP12可能是MLCK的下游效应物。我们的研究结果表明AKAP12参与胞质分裂进程的调控,并提示了AKAP12肿瘤抑制因子的新作用。